Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

A Randomized, Double-Blind, Active-Controlled, Parallel-Group, Multicenter Study to Determine the Efficacy and Safety of Albiglutide as Compared With Sitagliptin in Subjects With Type 2 Diabetes Mellitus With Renal Impairment
albiglutide
GLP114130
NCT01098539
Diabetes Mellitus, Type 2
Phase 3
 
This study is available in CDISC format
November 2014

Powered by ideaPoint, Inc.